Affinity crosslinking of 125I-labeled human beta-endorphin to cell lines possessing either mu- or delta-type opioid binding sites. 1988

O Keren, and T L Gioannini, and J M Hiller, and E J Simon
Department of Psychiatry, New York University Medical Center, NY 10016.

The specific labeling of opioid receptor-related polypeptides was compared in two cell lines which differ in their opioid receptor population: SK-N-SH which contains predominantly mu-type opioid receptors, and NG-108-15, which contains exclusively delta-type opioid receptors. Labeling of opioid receptors was achieved by affinity cross-linking of membranes, using 125I-labeled human beta-endorphin, followed by solubilization in sodium dodecyl sulphate (SDS), SDS-gel electrophoresis and autoradiography. Different labeling patterns were obtained from these two cell lines. In SK-N-SH cells, 3 major proteins were labeled, corresponding to molecular weights of 92, 65 and 25 kDa, while in the NG-108-15 cells, 53-kDa and 25-kDa polypeptides were the major ones labeled. The radioactivity incorporated into the 92- and 65-kDa peptide bands derived from SK-N-SH cells was displaced by the mu-selective ligand Tyr-D-Ala-Gly-MePhe-Gly-ol (DAGO) but not by the delta-selective ligand [D-Pen2,D-Pen5]enkephalin (DPDPE). The radioactivity incorporated into the NG-108-15-derived peptide bands was displaced by the delta-selective ligand, but not by the mu-selective ligand. This confirms our previous finding in mammalian brain which demonstrated that mu- and delta-opioid binding sites can be identified as distinct proteins which differ in molecular size.

UI MeSH Term Description Entries
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001615 beta-Endorphin A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN. Endorphin, beta,beta-Endorphin (1-31),beta Endorphin
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors
D017465 Receptors, Opioid, delta A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins. Opioid Receptors, delta,Receptors, delta,Receptors, delta Opioid,delta Receptors,delta Opioid Receptor,delta Receptor,Opioid Receptor, delta,Receptor, delta,Receptor, delta Opioid,delta Opioid Receptors
D020875 Enkephalin, Ala(2)-MePhe(4)-Gly(5)- An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments. D-Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin,DAMGO,2-Ala-4-MePhe-5-Gly-Enkephalin,Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin,D-Ala2-NMe-Phe4-Gly-ol Enkephalin,DAGO,DAGOL,DAMGE,Enkephalin, alanyl(2)-methylphenylalanyl(4)-glycine(5)-,RX-783006,Tyr-Ala-Gly-(NMe)Phe-Gly-ol,2 Ala 4 MePhe 5 Gly Enkephalin,D Ala2 NMe Phe4 Gly ol Enkephalin,Enkephalin, D-Ala2-NMe-Phe4-Gly-ol,RX 783006
D020881 Enkephalin, D-Penicillamine (2,5)- A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity. D-Pen2, D-Pen5-Enkephalin,D-Penicillamine (2,5)-Enkephalin,DPDPE,Bis-Pen-Enkephalin,Bis-Penicillamine-Enkephalin,D-Pen2, L-Pen5-Enkephalin,DPDPE(SH)2,DPLPE,Enkephalin, Pen(2,5)-,Enkephalin, Penicillamine (2,5)-,Bis Pen Enkephalin,Bis Penicillamine Enkephalin,D Pen2, D Pen5 Enkephalin,D Pen2, L Pen5 Enkephalin,D-Pen5-Enkephalin D-Pen2,L-Pen5-Enkephalin D-Pen2

Related Publications

O Keren, and T L Gioannini, and J M Hiller, and E J Simon
July 1989, European journal of pharmacology,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
January 1982, Life sciences,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
February 1989, Brain research. Developmental brain research,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
March 1992, Brain research. Developmental brain research,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
January 1992, Life sciences,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
January 1995, Life sciences,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
April 1990, The Journal of pharmacology and experimental therapeutics,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
January 1990, Progress in clinical and biological research,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
July 1986, Proceedings of the National Academy of Sciences of the United States of America,
O Keren, and T L Gioannini, and J M Hiller, and E J Simon
September 1986, Journal of biochemistry,
Copied contents to your clipboard!